{"id":"W2767174961","doi":"10.1016/j.jval.2017.08.2986","title":"Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study: Latin American Subgroup Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Visual analogue scale; Rheumatoid arthritis; Internal medicine; Methotrexate; Combination therapy; Physical therapy; Subgroup analysis; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002395763,0.0009763151,0.002422446,0.001092205,0.0003424813,0.001201388,0.0005971501,0.0006643451,0.002078013],"category_scores_gemma":[0.003248557,0.0003180068,0.006472452,0.001725007,0.0002971607,0.0005419576,0.0009255564,0.001111172,0.0002223822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006224126,"about_ca_system_score_gemma":0.0008151248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005405495,"about_ca_topic_score_gemma":0.0129779,"domain_scores_codex":[0.9982793,0.0006267166,0.0002515621,0.000332413,0.0001946576,0.0003153244],"domain_scores_gemma":[0.9989353,0.0003924681,0.0003263596,0.0001503222,0.0001141724,0.00008135766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07388378,0.0005017242,0.7213359,0.00286073,0.158269,0.0005802614,0.0004032038,0.001350299,0.002804547,0.0006104218,0.007163749,0.03023638],"study_design_scores_gemma":[0.01840295,0.002862311,0.8431683,0.0005610918,0.1215813,0.000488428,0.001380762,0.002425815,0.0007425051,0.001276593,0.006983606,0.0001264286],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747657,0.01495378,0.0009035993,0.0004668511,0.0001764857,0.0002389637,0.006009936,0.00003802293,0.002446685],"genre_scores_gemma":[0.993423,0.001385842,0.0002352182,0.0005109556,0.000118757,0.0002743993,0.003390387,0.00002454911,0.0006369221],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005405495,"threshold_uncertainty_score":0.01267016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06600752135216663,"score_gpt":0.3868284313646635,"score_spread":0.3208209100124969,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}